A Study of Nevirapine to Prevent HIV Transmission From Mothers to Their Babies

PHASE3CompletedINTERVENTIONAL

Enrollment

1,244

Participants

Timeline

Start Date

Not specified

Study Completion Date

May 31, 2001

Conditions

HIV InfectionsPregnancy

Interventions

DRUG

Nevirapine

Trial Locations (5)

Hopital Hotel Dieu de Lyon, Lyon

CHRU de Nantes, Nantes

Universita Frederico II, Napoli

Hosp Doce De Octubre, Madrid

Princess Margaret Hosp, Nassau

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00000942 - A Study of Nevirapine to Prevent HIV Transmission From Mothers to Their Babies | Biotech Hunter | Biotech Hunter